A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
Clinical trial NCT07221162 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07221162
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-05
- Primary completion
- 2026-11-24
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.